Peptides/MHC-I complexes and CD8+T cells

肽/MHC-I 复合物和 CD8 T 细胞

基本信息

  • 批准号:
    6627803
  • 负责人:
  • 金额:
    $ 27.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1993
  • 资助国家:
    美国
  • 起止时间:
    1993-07-07 至 2005-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (provided by applicant) Clinical and experimental evidence point to a critical role for CD8' T cells in immune defenses against intracellular pathogens. Foremost among these pathogens are those responsible for the AIDS pandemic, malaria, and tuberculosis. Distinctive proteins of many cancer cells, as well as prions, can also be considered to be intracellular pathogens. To help develop vaccines that promote defenses against these pathogens, we are studying some heat shock fusion proteins (Hsfp) that stimulate CD8 T cell responses. The Hsfp are formed from a recombinant mycobacterial (BCG) 57kDa heat shock protein, called hsp65, fused at its C-terminus with a "fusion partner" (a polypeptide or large protein domain). Fusion partners contain peptide sequences that, when excised in antigen-presenting (dendritic) cells and bound to the cells' class I MHC molecules, can activate CD8 T cells. It is likely that the effectiveness of CD8 T cell vaccines depends upon their ability to stimulate the production of a sufficient number of potent memory CD8 T cells, able to lyse target cells displaying very few cognate peptide-MHC complexes, because many virus-infected cells and cancer cells have low levels of MHC-I molecules and low copy numbers of some cognate peptides. We will study how Hsfp are taken into and proteolytically cleaved by dendritic cells (DC) and how these processes are affected by modifiers of DC behaviour, including double-stranded RNA and ligands for pattern-recognition receptors on these cells. The overall goal is to help provide a platform to aid in the development of immunization strategies leading to increased yields of potent memory CD8 T cells.
描述:(由申请人提供)临床和实验证据点

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HERMAN N EISEN其他文献

HERMAN N EISEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HERMAN N EISEN', 18)}}的其他基金

VACCINES ELICITING CD8 CYTOTOXIC T CELL RESPONSES
引发 CD8 细胞毒性 T 细胞反应的疫苗
  • 批准号:
    2767092
  • 财政年份:
    1998
  • 资助金额:
    $ 27.51万
  • 项目类别:
VACCINES ELICITING CD8 CYTOTOXIC T CELL RESPONSES
引发 CD8 细胞毒性 T 细胞反应的疫苗
  • 批准号:
    2887928
  • 财政年份:
    1998
  • 资助金额:
    $ 27.51万
  • 项目类别:
VACCINES ELICITING CD8 CYTOTOXIC T CELL RESPONSES
引发 CD8 细胞毒性 T 细胞反应的疫苗
  • 批准号:
    6170747
  • 财政年份:
    1998
  • 资助金额:
    $ 27.51万
  • 项目类别:
VACCINES ELICITING CD8 CYTOTOXIC T CELL RESPONSES
引发 CD8 细胞毒性 T 细胞反应的疫苗
  • 批准号:
    6374046
  • 财政年份:
    1998
  • 资助金额:
    $ 27.51万
  • 项目类别:
VACCINES ELICITING CD8 CYTOTOXIC T CELL RESPONSES
引发 CD8 细胞毒性 T 细胞反应的疫苗
  • 批准号:
    6511093
  • 财政年份:
    1998
  • 资助金额:
    $ 27.51万
  • 项目类别:
PEPTIDES/MHC I COMPLEXES AND CD8+ T CELLS
肽/MHC I 复合物和 CD8 T 细胞
  • 批准号:
    6172323
  • 财政年份:
    1993
  • 资助金额:
    $ 27.51万
  • 项目类别:
PEPTIDE/MHC-I COMPLEXES AND CD8+ T-CELLS
肽/MHC-I 复合物和 CD8 T 细胞
  • 批准号:
    2101441
  • 财政年份:
    1993
  • 资助金额:
    $ 27.51万
  • 项目类别:
PEPTIDE/MHC-I COMPLEXES AND CD8+ T-CELLS
肽/MHC-I 复合物和 CD8 T 细胞
  • 批准号:
    2101440
  • 财政年份:
    1993
  • 资助金额:
    $ 27.51万
  • 项目类别:
PEPTIDE/MHC-I COMPLEXES AND CD8+ T CELLS
肽/MHC-I 复合物和 CD8 T 细胞
  • 批准号:
    2824871
  • 财政年份:
    1993
  • 资助金额:
    $ 27.51万
  • 项目类别:
NATURAL HIV-1 PEPTIDES AND CD8+ CYTOTOXIC T-CELLS
天然 HIV-1 肽和 CD8 细胞毒性 T 细胞
  • 批准号:
    2442546
  • 财政年份:
    1993
  • 资助金额:
    $ 27.51万
  • 项目类别:

相似海外基金

ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
  • 批准号:
    3145834
  • 财政年份:
    1990
  • 资助金额:
    $ 27.51万
  • 项目类别:
ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
  • 批准号:
    3145832
  • 财政年份:
    1990
  • 资助金额:
    $ 27.51万
  • 项目类别:
ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
  • 批准号:
    3145835
  • 财政年份:
    1990
  • 资助金额:
    $ 27.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了